Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma. Catalog Number: CH2O0
This recall has been terminated (originally issued June 22, 2022).
- Recall Initiated
- June 22, 2022
- Terminated
- May 10, 2024
- Recall Number
- Z-1424-2022
- Quantity
- 15 kits
- Official Source
- View on FDA website ↗
Reason for Recall
Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.
Distribution
Nationwide Distribution - MD, OR, PR, MT, WV
Lot / Code Info
GTIN : 05055273201130 Lot Number: 586177 Expiry Date: 28th Jan 2024
Root Cause
Process design
Action Taken
Randox issued recall notification extended to the distribution center within the USA via email. The distributor will then contact the customer directly. The initial contact and the follow up contact will be via email. If further contacts are required these will be via telephone. It is intended that the initial contact will be conducted week beginning 27 Jun 22. Letter states reason for recall, health risk and action to take: Discontinue use of and discard any of the above batches immediately. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days.